Autoimmune Diseases  >>  Epratucyn (epratuzumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Epratucyn (epratuzumab) / Gilead
NCT00624351 / 2007-002566-35: Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease

Checkmark ACR-ARHP 2014: EMBLEM; SL0008
Oct 2014 - Oct 2014: ACR-ARHP 2014: EMBLEM; SL0008
Checkmark EMBLEM trial for SLE
Jun 2014 - Jun 2014: EMBLEM trial for SLE
Checkmark ISPOR 2014: SLE (EMBLEM; EMBLEM OLE)
More
Completed
2b
227
US, Europe, RoW
Epratuzumab, Placebo
UCB Pharma
Systemic Lupus Erythematosus
08/09
08/09
NCT00660881 / 2007-002589-37: Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease

Checkmark ACR-ARHP 2014: SL0008
Oct 2014 - Oct 2014: ACR-ARHP 2014: SL0008
Checkmark ACR-ARHP 2014: EMBLEM; SL0008
Oct 2014 - Oct 2014: ACR-ARHP 2014: EMBLEM; SL0008
Checkmark ISPOR 2014: SLE (EMBLEM; EMBLEM OLE)
More
Completed
2b
210
US, Europe, RoW
Epratuzumab
UCB Pharma
Systemic Lupus Erythematosus
12/11
12/11
NCT00113971: Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Terminated
2
20
US
epratuzumab
UCB Pharma
Lupus Erythematosus, Systemic
03/07
06/07
NCT00383513: Study of Epratuzumab in Systemic Lupus Erythematosus

Checkmark ALLEVIATE; SL0006
Nov 2013 - Nov 2013: ALLEVIATE; SL0006
Checkmark SL0006
Apr 2013 - Apr 2013: SL0006
Checkmark P2 data - ACR/ARHP 2012 (SLE)
More
Completed
2
29
US
Epratuzumab
UCB Pharma
Systemic Lupus Erythematosus
01/12
01/12
NCT01534403: Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects

Completed
2
17
Japan
Epratuzumab
UCB Pharma
Systemic Lupus Erythematosus
02/15
02/15
NCT01449071: Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)

Completed
1/2
20
Japan
Placebo, Epratuzumab 400 mg, Epratuzumab 1200 mg, Epratuzumab 100 mg, Epratuzumab 600 mg
UCB Pharma
Systemic Lupus Erythematosus
03/13
03/13

Download Options